ARCA Biopharma - 53 Year Dividend History | ABIO
Historical dividend payout and yield for ARCA Biopharma (ABIO) since 1971. The current TTM dividend payout for ARCA Biopharma (ABIO) as of April 23, 2024 is $0.00. The current dividend yield for ARCA Biopharma as of April 23, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.050B |
$0.000B |
|
ARCA biopharma, Inc., a biopharmaceutical company, develops genetically-targeted therapies for heart failure and cardiovascular diseases. It is positioned to bring personalized therapies for the treatment of cardiovascular disease, through the use of genetics. Complementing the Company's cardiovascular science, ARCA's management team has significant experience in developing and commercializing cardiovascular products. The Company's business focus combines expertise in cardiovascular pathophysiology, molecular genetics, clinical development and product commercialization. It is currently developing Gencaro (bucindolol hydrochloride), a cardiovascular drug for the treatment of chronic heart failure. The company is based in Broomfield, Colorado.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
